The Ethics Blog

A research blog from the Centre for Resarch Ethics & Bioethics (CRB)

Page 26 of 50

Two measures against the culture of honorary authorships

It is important in the academia to know who actually contributed as author to scientific publications. Partly because authorship is meritorious when researchers seek positions and funding. Partly to facilitate investigations of suspected research misconduct. These are two important reasons why there are guidelines for academic authorship. These guidelines state that an author should not […]

Continue reading

Prepare for robot nonsense

As computers and robots take over tasks that so far only humans could carry out, such as driving a car, we are likely to experience increasingly insidious uses of language by the technology’s intellectual clergy. The idea of ​​intelligent computers and conscious robots is for some reason terribly fascinating. We see ourselves as intelligent and […]

Continue reading

Inequalities in healthcare – from denial to greater awareness

Swedish law prescribes healthcare on equal terms for the whole population. Complying with this law is more difficult than one might believe, since discrimination tends to happen unknowingly, under our own radar. Telephone nursing has been thought to increase equality in healthcare, because it is so easily accessible. However, research has demonstrated inequalities in telephone […]

Continue reading

Not knowing why

Often we do not know why we think as do. We may like a drawing, but we cannot say why we think it is good. We may find it unpleasant that researchers study human embryos in petri dishes and then discard them, but we cannot say why. Personally, I find not knowing why interesting and […]

Continue reading

Hoping when there is no hope

Patients participating in phase I oncology trials have terminal cancer and are near the end of life. Participating in research cannot cure them or even extend their lives. Not only because they have terminal cancer, but also because in phase I trials one tests the safety profile of the treatment, not effectiveness against cancer. Nevertheless, […]

Continue reading
« Older posts Newer posts »